These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 8875625)

  • 21. Viral pathogenesis of hepatocellular carcinoma in the United States.
    Liang TJ; Jeffers LJ; Reddy KR; De Medina M; Parker IT; Cheinquer H; Idrovo V; Rabassa A; Schiff ER
    Hepatology; 1993 Dec; 18(6):1326-33. PubMed ID: 8244256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increasing incidence of hepatocellular carcinoma possibly associated with non-A, non-B hepatitis in Japan, disclosed by hepatitis B virus DNA analysis of surgically resected cases.
    Sakamoto M; Hirohashi S; Tsuda H; Ino Y; Shimosato Y; Yamasaki S; Makuuchi M; Hasegawa H; Terada M; Hosoda Y
    Cancer Res; 1988 Dec; 48(24 Pt 1):7294-7. PubMed ID: 2847867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of GST-pi and HBV infection in hepatocellular carcinoma].
    Shen LJ; Zhang ZJ; Zhang HX; Yang WB; Huang R
    Ai Zheng; 2002 Jan; 21(1):29-32. PubMed ID: 12500393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California.
    Yu MC; Yuan JM; Ross RK; Govindarajan S
    Hepatology; 1997 Jan; 25(1):226-8. PubMed ID: 8985295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigms.
    Brechot C; Kremsdorf D; Soussan P; Pineau P; Dejean A; Paterlini-Brechot P; Tiollais P
    Pathol Biol (Paris); 2010 Aug; 58(4):278-87. PubMed ID: 20667665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequencing of human-viral DNA junctions in hepatocellular carcinoma from patients with HCV and occult HBV infection.
    Tamori A; Nishiguchi S; Kubo S; Enomoto M; Koh N; Takeda T; Shiomi S; Hirohashi K; Kinoshita H; Otani S
    J Med Virol; 2003 Apr; 69(4):475-81. PubMed ID: 12601754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis viruses as aetiological agents of hepatocellular carcinoma.
    Alberti A; Pontisso P
    Ital J Gastroenterol; 1991; 23(7):452-6. PubMed ID: 1660332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus chronic liver disease and hepatocellular carcinoma.
    Zuckerman AJ; Harrison TJ
    Postgrad Med J; 1987; 63 Suppl 2(737):13-9. PubMed ID: 2825153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
    J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of hepatitis C virus and hepatocellular carcinoma in the United States.
    Reid AE; Liang TJ
    Princess Takamatsu Symp; 1995; 25():41-9. PubMed ID: 8875608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
    Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
    Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma.
    Caselmann WH; Alt M
    J Hepatol; 1996; 24(2 Suppl):61-6. PubMed ID: 8836891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral co-factors in liver cancer: lessons from hepatitis B virus.
    Butel JS; Lee TH; Slagle BL
    Princess Takamatsu Symp; 1995; 25():185-98. PubMed ID: 8875624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with hepatitis B- or C-related hepatocellular carcinoma.
    Chen MF; Jeng LB; Lee WC; Chen TC
    Surgery; 1998 May; 123(5):554-9. PubMed ID: 9591008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection?
    Huo TI; Huang YH; Hsia CY; Su CW; Lin HC; Hsu CY; Lee PC; Lui WY; Loong CC; Chiang JH; Chiou YY; Lee SD
    Liver Int; 2009 May; 29(5):767-73. PubMed ID: 19018974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histocompatibility antigens in patients with hepatocellular carcinoma and their relationship to chronic hepatitis B virus infection in these patients.
    Kew MC; Gear AJ; Baumgarten I; Dusheiko GM; Maier G
    Gastroenterology; 1979 Sep; 77(3):537-9. PubMed ID: 222645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.
    Chiesa R; Donato F; Tagger A; Favret M; Ribero ML; Nardi G; Gelatti U; Bucella E; Tomasi E; Portolani N; Bonetti M; Bettini L; Pelizzari G; Salmi A; Savio A; Garatti M; Callea F
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):213-6. PubMed ID: 10698484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America.
    Hsia CC; Scudamore CH; Di Bisceglie AM; Tabor E
    J Med Virol; 2003 May; 70(1):20-6. PubMed ID: 12629639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.